Trial intelligence / Profile preview

Progesterone for Drug-Induced QT Prolongation

NCT01929083Phase 2Completed

Sponsor
Indiana University
Start
Apr 2013
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of progesterone in Long QT syndrome (LQTS), sponsored by Indiana University. Started Apr 2013; status: completed.

02

Drugs

progesterone
03

Conditions

Long QT syndrome (LQTS)

Beyond the preview

Go deeper on NCT01929083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01929083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call